SurModics Inc (SRDX)

[foolishpremise]

Thanks for the replies. End of 2009 for European approval sounds encouraging for SRDX as it is a promising stent. I think fully biodegradable stents is where the market will eventually go but I would wager there will be unforeseen technical hurdles which will delay its arrival for several years. Drug eluting balloons are an intriguing concept - in part because they let you choose your favorite BMS to follow. There was info in the uncoated stent days that suggested thinner struts might produce less restenosis - and thin struts are difficult to accomplish when you are applying a coating on top of the struts.

The trial which has always made the most sense to me is the best in class BMS with a couple of days peri-procedural oral prednisone versus the best in class DES. This, of course, runs contrary to the interests of the device companies which fund such research (as it is a much less expensive option) so you won’t see it happen (despite some promising early work).